Kabra Drugs informs about disclosure

01 Feb 2018

Kabra Drugs has informed about disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Related Kabra Drugs Ltd. Links:

Kabra Drugs Share Price

0.73 0.00 (0.00%) Nov 07, 17:53
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 421.55
Lupin 735.95
Dr. Reddys Lab 2815.05
Piramal Enterprises 1781.25
Cadila Healthcare 230.25
View more..
Sensex vs Kabra Drugs
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323
Research Analyst - INH000000719

Callback

8055769463

8055769463